1. Why is the FDA now interested in measuring PROs?
2. Identify 3 problems with existing health-related quality of life PROs for type 1 diabetes.
3. List 2 common themes of health-related quality of life across different stages of development.
03/11/2019 - 5:00pm to 6:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Barbara J. Anderson, Ph.D.